News out on STEM
StemCells, Inc. to Present at Neurodegenerative Conditions Research and Development Conference
StemCells,Inc. (Nasdaq:STEM) announced today that President and CEO Martin McGlynn will make a presentation on the Company's programs and operations at the 6th Neurodegenerative Conditions Research and Development conference. Mr. McGlynn is scheduled to speak at 11:35 a.m. Pacific Time on Friday,September 14. The Neurodegenerative Conditions Research and Development session is part of the 2nd CNS Diseases World Summit which will be held September 13-14 at the Hilton San Francisco Financial District hotel in downtown San Francisco.
The CNS Diseases World Summit brings together leading experts across industry and academia to discuss the latest research and developments in the CNS field. The summit has four parallel tracks that focus on neurodegenerative conditions,neuropsychiatric disorders,pain research and therapeutics,and CNS partnering and deal-making. The Neurodegenerative Conditions track brings together leading scientists and experts to discuss latest breakthroughs,new drug targets, new models,the development of new biomarkers,imaging modalities,and several other novel developments and therapeutics to combat neurodegenerative conditions.
